Interleukin-8 Blockade Prevents Activated Endothelial Cell Mediated Proliferation and Chemoresistance of Acute Myeloid Leukemia

One of the greatest challenges in treating acute myeloid leukemia (AML) is chemotherapy refractory disease. Previously, we demonstrated a novel mechanism whereby AML-induced endothelial cell (EC) activation leads to subsequent leukemia cell adherence, quiescence and chemoresistance, identifying acti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Leuk Res
Glavni autori: Vijay, Vindhya, Miller, Regan, Vue, Gau Shoua, Pezeshkian, Mida Bahareh, Maywood, Michael, Ast, Allison M., Drusbosky, Leylah M., Pompeu, Yuri, Salgado, Alan D., Lipten, Samuel D., Geddes, Timothy, Blenc, Ann Marie, Ge, Yubin, Ostrov, David A., Cogle, Christopher R., Madlambayan, Gerard J
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857733/
https://ncbi.nlm.nih.gov/pubmed/31299413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2019.106180
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items